Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meridian Diagnostics

This article was originally published in The Gray Sheet

Executive Summary

Completes offering of $11.5 mil. in 7.25% convertible subordinated debentures due 2001. The offering was underwritten by The Ohio Company and Roney & Co. Approximately $2.8 mil. of the anticipated $10.9 mil. in proceeds will be used to repay indebtedness related to the June 17 acquisition of MonoSpot and Monolert mononucleosis assays from Johnson & Johnson's Ortho Diagnostic Systems ("The Gray Sheet" Dec. 12, 1988, p. 30). The remaining proceeds will be used for capital improvements and general corporate purposes "including possible acquisitions." The debentures are convertible into shares of common stock prior to maturity at the rate of $9.50 per share.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel